Medical Care Technologies Inc. (OTC Pink:MDCE) Closes Reg A - Dilution Ends, Growth Phase Begins

Rhea-AI Summary

Medical Care Technologies (OTC Pink: MDCE) announced its Regulation A Tier 1 offering will formally conclude on December 6, 2025, ending the dilution period tied to that offering and stopping further share issuance under Reg A.

The company said proceeds from the offering, together with an intentionally lean cost structure, have positioned MDCE to focus on product launches, revenue expansion, and AI innovation throughout 2026. Planned initiatives include a debut consumer-facing nutrition intelligence and recipe generation mobile platform and continued growth of subsidiaries Infinite Auctions and Real Game Used.

Positive

• Reg A offering set to conclude on December 6, 2025
• No additional shares to be issued through the Reg A offering
• Proceeds earmarked to fund AI mobile apps and product launches in 2026
• Capital supports growth of subsidiaries Infinite Auctions and Real Game Used

Negative

• None.

News Market Reaction

+40.00%

1 alert

+40.00% News Effect

On the day this news was published, MDCE gained 40.00%, reflecting a significant positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Reg A end date: December 6, 2025 Growth focus year: 2026

2 metrics

Reg A end date December 6, 2025 Regulation A Tier 1 offering formally concludes

Growth focus year 2026 Management targets product launches, revenue expansion, AI innovation

Market Reality Check

Price: $0.0003 Vol: Volume 62,888,866 is 28% ...

normal vol

$0.0003 Last Close

Volume Volume 62,888,866 is 28% above the 20-day average of 49,205,049. normal

Technical Price at $0.0004, reported as above 200-day MA of $0.

Peers on Argus

MDCE fell 16.67% while closest peers were mixed: YUKA down 5.45%, BBTT up 1.52%,...

MDCE fell 16.67% while closest peers were mixed: YUKA down 5.45%, BBTT up 1.52%, others flat. Moves do not show a unified sector trend.

Historical Context

5 past events · Latest: Dec 09 (Positive)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Dec 09	Partnership update	Positive	-14.3%	Highlighted share-structure stabilization and new AI tech partnership activity.
Dec 08	AI product update	Positive	+0.0%	Announced integration of Google-backed dermatology AI into skin app.
Dec 05	Capital structure	Positive	+40.0%	Confirmed Reg A completion and focus on growth and AI initiatives.
Dec 04	AI strategy	Positive	+0.0%	Outlined plan to build AI apps leveraging existing revenue subsidiaries.
Dec 03	Operating model	Positive	+0.0%	Described lean AI model emphasizing outsourcing and API-based innovation.

Pattern Detected

Recent AI and corporate-transition news has mostly seen aligned or muted price reactions, with one notable negative divergence despite positive partnership updates.

Recent Company History

Over early December 2025, MDCE released a rapid sequence of updates: a lean AI operating model (Dec 3), plans to leverage revenue-generating subsidiaries for AI apps (Dec 4), the Reg A closure and shift to a growth phase (Dec 5), AI dermatology positioning with a Google-backed model (Dec 8), and a follow-up on investor activity and partnership progress (Dec 9). The current Reg A conclusion fits into this broader pivot toward AI health and consumer applications.

Market Pulse Summary

The stock surged +40.0% in the session following this news. A strong positive reaction aligns with t...

Analysis

The stock surged +40.0% in the session following this news. A strong positive reaction aligns with the company’s message that dilution under its Regulation A Tier 1 offering ended on December 6, 2025, shifting focus to growth. Historical news over early December showed mostly aligned or muted moves to positive AI and strategy updates. Investors would need to weigh execution on 2026 product launches and the large share float of 3,243,896,955 when assessing how durable any upside might be.

Key Terms

regulation a tier 1 offering, reg a, ai-powered

3 terms

regulation a tier 1 offering regulatory

"its Regulation A Tier 1 Offering will formally conclude on December 6, 2025"

A Regulation A Tier 1 offering is a simplified way for a private company to sell shares to the public without doing a full traditional IPO; it uses a scaled-down registration process intended for smaller capital raises. It matters to investors because it opens access to early-stage or smaller public investments with less disclosure than a full IPO and usually involves state-level review, so buyers should weigh higher uncertainty and potentially lower liquidity against the chance for early access to growth.

reg a regulatory

"no additional shares will be issued through the Reg A, concluding the dilution"

Reg A is a US securities rule that lets smaller companies raise money from the public with a simplified registration process, like a short-form fundraising brochure instead of a full, technical prospectus. It matters to investors because it widens access to early-stage or growing companies that otherwise would only seek private funding, but these offerings can be riskier and less liquid than established public stocks, so buyers should weigh potential reward against limited oversight and resale constraints.

ai-powered technical

"development of our AI-powered health and nutrition technologies at full speed"

"AI-powered" describes technology that uses artificial intelligence to perform tasks, make decisions, or analyze information automatically. It’s similar to having a highly skilled assistant that can learn from data, recognize patterns, and improve over time, helping to make processes faster and more accurate. For investors, this means better insights and more efficient operations, potentially leading to smarter investment choices.

AI-generated analysis. Not financial advice.

MESA, ARIZONA / ACCESS Newswire / December 5, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE) is pleased to announce that its Regulation A Tier 1 Offering will formally conclude on December 6, 2025, marking a major milestone in the Company's corporate transition and strengthening its capital structure.

With the completion of the offering, no additional shares will be issued through the Reg A, concluding the dilution period that supported early-stage development and strategic subsidiary growth. Coupled with the Company's intentionally lean operational model, the proceeds from the offering have positioned MDCE with the financial flexibility needed to focus aggressively on product launches, revenue expansion, and AI innovation throughout 2026.

"We built a foundation to scale - and now we're ready to accelerate," said Marshall Perkins III, CEO of Medical Care Technologies Inc. "By completing our Reg A and maintaining a lower-overhead model, we are now in the driver's seat to push forward the development of our AI-powered health and nutrition technologies at full speed."

The Company highlighted that the capital raised will directly support the rollout of MDCE's forthcoming catalog of consumer-focused AI mobile applications - including its debut nutrition intelligence and recipe generation platform - as well as continued growth of its established subsidiaries Infinite Auctions and Real Game Used.

"We want our investors to know that this moment marks the transition into our growth phase," added Perkins. "We are incredibly excited for what's next."

---

About Medical Care Technologies Inc.

Medical Care Technologies Inc. (www.medicalcaretechnologies.com, www.mdcestock.com) is an emerging health-technology company creating AI-driven consumer applications across wellness, nutrition, and preventive screening. Fueled by proven subsidiary operations and a lean innovation strategy, the Company is focused on scalable AI products designed to improve everyday health and lifestyle decisions.

---

Safe Harbor Statement

This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially due to various risks and uncertainties. The Company assumes no obligation to update forward-looking statements.

Contact:

Investor Relations
Medical Care Technologies Inc.
info@infiniteauctions.com
Website: www.mdcestock.com

SOURCE: Medical Care Technologies Inc. (OTC Pink:MDCE)

View the original press release on ACCESS Newswire

FAQ

What does Medical Care Technologies (MDCE) announcing Reg A closure on December 6, 2025 mean for shareholders?

The company says the Reg A will end dilution because no more shares will be issued under that offering after December 6, 2025.

How will MDCE use the funds raised from the Regulation A offering for 2026 initiatives?

MDCE states proceeds will support product launches, revenue expansion, and AI innovation, including a nutrition intelligence mobile platform.

Will Medical Care Technologies (MDCE) issue more shares under the Reg A after December 6, 2025?

No; the company announced that no additional shares will be issued through the Reg A offering once it concludes.

Which MDCE subsidiaries are named for continued growth after the Reg A completion?

The company specifically named Infinite Auctions and Real Game Used as subsidiaries targeted for continued growth.

Does MDCE link the Reg A completion to changes in its operating model or costs?

MDCE described maintaining a lower-overhead operational model and said the capital from the offering supports its shift into a growth phase.